Table 2.
Demographic, clinical, and gadolinium deposition characteristics of patients with multiple sclerosis (MS) at baseline and follow-up, according to median number of gadodiamide doses administered
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.